Driving Innovation in Biotech Engineering: A Conversation with AES’ VP of Process Engineering, Jim Ball
In this Q&A, Jim shares his journey, highlights the unique capabilities of AES’s Process Engineering team, and discusses the company’s vision for driving growth and excellence in the biotech industry.
Table of Contents
At AES, leadership is not just about guiding teams but also about shaping the future of biotechnology and engineering. Jim Ball, our Vice President of Process Engineering, exemplifies this principle with his hands-on approach to innovation and commitment to building scalable, compliant, and impactful solutions for our clients.
Q: Jim, what excites you most about your role at AES?
Jim: There’s so much I love about my role at AES. What excites me most is the variety of work and the constant opportunities to learn. I get to dive into highly technical engineering design, process development, project management, and even mentoring teams to build their skills. It’s a role that challenges me daily, and I thrive on that.
The caliber of people I work with is incredible, and the projects we take on push us to think creatively and deliver exceptional results. Rarely is there a dull moment, and that’s what keeps me energized and passionate about what I do.
Q: How would you describe the mission of the Process Engineering team and its impact on AES clients?
Jim: Our team’s mission is to bring projects to life by partnering with clients to understand their unique challenges and deliver solutions that are scalable, compliant, and tailored to their long-term goals. We go deeper than traditional project management teams focusing on timelines and scope.
We design, build, and integrate systems from lab-scale processes to full-scale commercial production. Our approach ensures that the solutions we deliver solve immediate problems and support our clients’ growth for years to come. Our work directly impacts their ability to remain competitive in an ever-evolving industry.
Q: What unique challenges does your team address when scaling lab systems to full-scale production?
Jim: Scaling isn’t just about making systems larger—it’s about managing complexity. At a lab scale, processes move quickly, and adjustments are relatively simple. But when you scale to commercial production, you encounter challenges in three main areas: technology, people, and compliance.
For example, lab systems may only require a few scientists to operate, but full-scale production can need five times as many operators with varying levels of expertise. This requires advanced control systems, robust training programs, and detailed reporting mechanisms to ensure compliance and consistency.
AES excels in addressing these challenges. We provide everything from engineering and project management to validation and qualification, ensuring clients have a fully functioning, compliant facility.
Q: What sets AES apart in system integration and engineering services for life sciences?
Jim: Simply put, we offer end-to-end solutions. We can take an empty warehouse, brownfield, or greenfield site and deliver a fully functioning manufacturing facility—on time, under budget, and with exceptional quality. Many of our competitors provide equipment but leave the rest to the client. At AES, we design equipment specific to the client’s process. We build, install, test, and qualify it and even provide staff to run it if needed. I don’t know of any other company in the industry that offers this partnership level.
Q: How has your career prepared you for your current role at AES?
Jim: My career journey has been mission-driven from the start. I began in operations as a production supervisor and have since worked across manufacturing, engineering, quality systems, and supply chain. Each role taught me something new about the intersection of technology, people, and processes.
At Genentech, I learned state-of-the-art manufacturing processes and top-tier quality management systems. At Lonza and Takeda, I tackled more complex roles that broadened my expertise in regulatory compliance, operational efficiency, and leadership.
These experiences gave me the technical depth and leadership skills needed to lead a team like the one at AES, where we’re constantly innovating and driving excellence.
Q: How do you foster a culture of growth and innovation within your team?
Jim: It starts with asking the right questions and defining the right outcomes. I challenge my team to fully understand the problem before jumping into solutions. A well-defined problem is half-solved, and from there, I rely on the diverse talents of our engineers to innovate and collaborate.
We focus on delivering solutions that are compliant and high-quality and push the boundaries of what’s possible. I encourage continuous learning and allow my team to explore creative approaches to solving complex problems.
Q: What trends in life sciences are you most excited about, and how is AES positioned to support them?
Jim: The life sciences industry is evolving rapidly, with breakthroughs in oncology, immunology, and cell and gene therapies leading the way. What excites me most is the innovation aimed at addressing unmet medical needs.
AES is uniquely positioned to support these trends because of our talented team and advanced capabilities. We understand the engineering and science behind designing, developing, and delivering compliant, high-quality solutions across multiple platforms. Whether it’s single-use technology or automation, we stay at the cutting edge to meet the demands of the industry.
Q: Where do you see AES making the most significant impact in the next five years?
Jim: I see AES expanding into emerging markets like the Middle East and Asia, bringing high-quality engineering solutions to regions just starting to develop advanced biopharma capabilities.
At the same time, we’ll continue to support our clients in the U.S. and Europe with innovative solutions that help them stay ahead of the curve. Our ability to deliver across diverse geographies and modalities will be a key driver of our impact in the future.

Jim Ball’s leadership reflects AES’s commitment to innovation, excellence, and partnership. By addressing complex challenges in process engineering, AES empowers clients to scale operations, maintain compliance, and stay competitive in a dynamic industry.
With a focus on fostering talent, embracing innovation, and delivering end-to-end solutions, AES is well-positioned to lead the way in biotech and engineering for years to come.